Biohit Oyj (OHEL:BIOBV) ROE % Adjusted to Book Value : 3.24% (As of Dec. 2023)

View and export this data going back to 1999. Start your Free Trial

What is Biohit Oyj ROE % Adjusted to Book Value?

Biohit Oyj's ROE % for the quarter that ended in Dec. 2023 was 9.79%. Biohit Oyj's PB Ratio for the quarter that ended in Dec. 2023 was 3.02. Biohit Oyj's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 was 3.24%.

Biohit Oyj ROE % Adjusted to Book Value Historical Data

The historical data trend for Biohit Oyj's ROE % Adjusted to Book Value can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biohit Oyj ROE % Adjusted to Book Value Chart

Biohit Oyj Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

ROE % Adjusted to Book Value

Get a 7-Day Free Trial

-2.68

-6.63

-4.96

2.57

7.26

Biohit Oyj Semi-Annual Data
	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
ROE % Adjusted to Book Value	Get a 7-Day Free Trial															-2.82	10.55	-2.47	11.42	3.24

Competitive Comparison of Biohit Oyj's ROE % Adjusted to Book Value

For the Biotechnology subindustry, Biohit Oyj's ROE % Adjusted to Book Value, along with its competitors' market caps and ROE % Adjusted to Book Value data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Biohit Oyj's ROE % Adjusted to Book Value Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Biohit Oyj's ROE % Adjusted to Book Value distribution charts can be found below:

* The bar in red indicates where Biohit Oyj's ROE % Adjusted to Book Value falls into.

Biohit Oyj ROE % Adjusted to Book Value Calculation

Biohit Oyj's ROE % Adjusted to Book Value for the fiscal year that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	21.93%	/	3.02
	=	7.26%

Biohit Oyj's ROE % Adjusted to Book Value for the quarter that ended in Dec. 2023 is calculated as

ROE % Adjusted to Book Value	=	ROE %	/	PB Ratio
	=	9.79%	/	3.02
	=	3.24%

Biohit Oyj ROE % Adjusted to Book Value Related Terms

Thank you for viewing the detailed overview of Biohit Oyj's ROE % Adjusted to Book Value provided by GuruFocus.com. Please click on the following links to see related term pages.

Biohit Oyj (OHEL:BIOBV) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Biohit Oyj (OHEL:BIOBV) » Definitions » ROE % Adjusted to Book Value

Comparable Companies

Traded in Other Exchanges

N/A

Address

Laippatie 1, Helsinki, FIN, 00880

Website

https://www.biohithealthcare.com

Biohit Oyj is a biotechnology company. It manufactures products that bind acetaldehyde, diagnostic products, and systems for diagnostic analysis for the use of research institutions, healthcare, and industry. Biohit's product portfolio consists of diagnostic tests, analysis systems, products that bind carcinogenic acetaldehyde into harmless compounds, monoclonal antibodies and service laboratory operations.

Biohit Oyj (OHEL:BIOBV) Headlines

No Headlines